Skip to main content

CAP TODAY/ AstraZeneca Webinar: A Multidisciplinary Approach to Molecular Testing in Resectable NSCLC

Thank you

This live web event has ended. Thank you for attending.

Description



A Multidisciplinary Approach to
Molecular Testing in Resectable NSCLC

Why should you register now for this webinar?

  • Learn about molecular testing in resectable Stage IB-IIIA NSCLC
  • Explore the clinical unmet need in resectable NSCLC
  • Discuss the best practices for molecular testing and the need for a coordinated
    multidisciplinary approach to help ensure quality molecular testing
Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenter: Samuel Caughron, MD, FCAP
You will have the opportunity to ask questions of our distinguished presenter.

CAP TODAY does not endorse any of the products or services named within. This webinar is sponsored by AstraZeneca. ©2021 AstraZeneca. All rights reserved. US-51347 Last Updated 3/21

Contributors

  • Sam Caughron, MD

    Pathologist, President & CEO, MAWD Pathology Group
    Chair of Pathology & Medical Director of Clinical Laboratory
    Advent Health Kansas City
    Lenexa, Kansas

  • Bob McGonnagle

    Publisher, CAP TODAY

April 22, 2021
Thu 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136